Diasome Pharmaceuticals
Biotechnology · Health Care
Overview
Diasome’s HDV™ platform redefines drug delivery by targeting the liver, improving treatment for diabetes, obesity, and metabolic dysfunction.
Funding and backers
Total raised
$44.6M
8 rounds on record
Latest round
$3.1M
Venture round · Jul 2024 · 2 yr ago
Team
51-200
employees, estimated range
The money's age
Long since its last round
27 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 31, 2024
Raised a round Venture round $3.1M · SEC Form D
Jun 22, 2023
Raised a round Venture round $9M · SEC Form D
Aug 26, 2022
Raised a round Venture round $16.7M · SEC Form D
Sep 21, 2020
Took on debt financing $1.5M · SEC Form D
Mar 17, 2020
Raised a round Venture round $2.9M · SEC Form D
Oct 12, 2018
Took on debt financing $12.1M · SEC Form D
Dec 16, 2016
Took on debt financing $4.4M · SEC Form D
Mar 27, 2008
Raised a round Venture round $12.9M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2024 | $3.1M | — | SEC Form D |
| Venture round | Jun 2023 | $9M | — | SEC Form D |
| Venture round | Aug 2022 | $16.7M | — | SEC Form D |
| Debt Financing | Sep 2020 | $1.5M | — | SEC Form D |
| Venture round | Mar 2020 | $2.9M | — | SEC Form D |
| Debt Financing | Oct 2018 | $12.1M | — | SEC Form D |
| Debt Financing | Dec 2016 | $4.4M | — | SEC Form D |
| Venture round | Mar 2008 | $12.9M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Diasome Pharmaceuticals, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Robert GehoExecutive Officer, DirectorSEC Form D
W. GehoExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated…
MitoRx is developing new treatments to restore healthy mitochondrial metabolism in patients living with high-risk obesity.
Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment.
NeuTigers turns existing consumer wearables into a privacy-preserving metabolic intelligence platform, backed by proprietary Edge-AI and…
Ilant provides comprehensive, employer-backed metabolic care. Drive meaningful health outcomes with expert clinical guidance, care teams…
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
Financials
Total raised
$62.5M
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $3.1M | Details |
| Venture - Series Unknown | 2023 | $9M | Details |
| Venture - Series Unknown | 2022 | $16.7M | Details |
| Debt Financing | 2020 | $1.5M | Details |
| Venture - Series Unknown | 2020 | $2.9M | Details |
| Debt Financing | 2018 | $12.1M | Details |
| Debt Financing | 2016 | $4.4M | Details |
| Venture - Series Unknown | 2008 | $12.9M | Details |
People
Robert Geho
Executive Officer, Director
W. Geho
Executive Officer, Director
Thomas McDonald
Director
Frank McCaney
Director
Cosme Ordonez
Director
Peter Tollman
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Cleveland
United States
HQ
Media
United States
Regional office
Media
10000 Cedar Avenue